Tuftsin’s Role in Cancer Treatment
Tuftsin has been identified as a peptide which plays an important part in cancer treatment. The primary structure of Tuftsin is composed of four amino acid: lysine (proline), threonine (threonine) and arginine. Tuftsin is used to treat cancer. It has been shown that it can stimulate tumor cell destruction. According to one study, “Tuftsin was found to possess a potent anti-tumor activity, which is mediated by the induction of apoptosis.” (Wang, et al. 2020). This indicates that tumor cells can be programmed to die by tuftsin, which in turn inhibits their future growth. Three peptide bonds form the primary structure of Tufsin. They link the proline and lysine amino and carboxyl group, along with the threonine, and arginine (Wang et. al. 2020). The peptide bonds allow the tuftsin molecules to communicate with the receptors of cancer cells’ surfaces, which triggers programmed cell death. To activate anti-tum, the amino group of arginaine must not be linked to other amino acids.